Form 4: Axon Enterprise Director Sells $271,628 Worth of Stock Through Pre-arranged 10b5-1 Trading Plan
Insider Trading Form 4 Filing
Axon Enterprise director Caitlin Elizabeth Kalinowski sold 450 shares of common stock on January 2, 2025, for a total of $271,628, according to a Form 4 filing with the SEC.
Summary
- Caitlin Elizabeth Kalinowski, a director at Axon Enterprise, sold 450 shares of common stock on January 2, 2025.
- The shares were sold at an average price of $604.07 per share, totaling $271,628.
- This transaction was executed under a Rule 10b5-1 trading plan adopted on August 20, 2024.
- Ms. Kalinowski's beneficial ownership in Axon Enterprise decreased to 6,929 shares following the sale.
Sentiment
Score: 5
Explanation: Neutral. While insider selling can sometimes be viewed negatively, the pre-arranged nature of this sale through a 10b5-1 plan mitigates those concerns. It's a routine transaction.
Positives
- The sale was conducted through a 10b5-1 trading plan, suggesting it was pre-planned and not a reaction to negative information.
Negatives
- A director selling shares can sometimes be perceived negatively by the market, although in this case it was pre-planned.
Key Dates
| Date | Description |
|---|---|
| August 20, 2024 | Date the Rule 10b5-1 trading plan was adopted. |
| January 2, 2025 | Date of the stock sale. |
Keywords
insider trading, form 4, sec filing, axon enterprise, 10b5-1 plan, stock sale, director, caitlin kalinowski
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.